ClinTec GmbH CEO, Dr Rabinder Buttar Named Top Business Woman of the Year at World’s First Sikh Awards Held in London

12th October 2010 -- ClinTec International CEO and President, Dr Rabinder Buttar won the prestigious ‘Business Woman of the Year’ at the Sikh Awards held on Sunday 10th October

The award ceremony was organised by the Sikh Directory and was attended by over 600 people at the Grosvenor House Hotel in London. The awards recognise the top Sikhs in Britain across the areas of Art, Sports, Entertainment, Education and Business. Baroness Young of Old Scone presented the Business Woman of the Year award to Dr Buttar during the ceremony.

On winning the award Dr Buttar commented “Sikhs in Britain are making a positive impact in all areas of British life including the important area of healthcare which affects us all. I am proud and honored to receive this award and thank all those who have supported me in making ClinTec the global success it is today. I started ClinTec from scratch and now have hugely committed employees present in 40 countries globally who are delivering excellence in clinical research to our clients who include 8 of the top 10 pharmaceutical companies in the world”.

Last night’s award success comes shortly after Dr Buttar was named Female Business Leader of the Year at the Scottish Leadership Awards held in Glasgow on 6th October 2010.

The winner of the Business Man of the Year award was Dr Kartar Singh Lalvani OBE who founded Britain’s fastest growing major nutraceutical company Vitabiotics. Others who received awards included Jazzy B, the world famous Punjabi entertainer and 94 year old marathon runner Fauja Singh.

About ClinTec International

ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.

In addition to ClinTec’s vast expertise in oncology, the organisation has also conducted over 400 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec’s fast, flexible and focused approach to clinical research ensures an added advantage to the drug development process. The organisations range of services includes Clinical Monitoring and Project Management, Regulatory Affairs, Medical Writing, Data Management and Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.

For further information please contact:

Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or bbal@clintec.com

For more information about ClinTec, please visit www.clintec.com

For media enquiries: please contact Tristan Jervis on 00 44 207 861 3019.

MORE ON THIS TOPIC